Profil

Curnel Alicia

Département de pharmacie > Développement de nanomédicaments

CIRM

See author's contact details
Main Referenced Co-authors
Berger, Manon  (4)
Evrard, Brigitte  (4)
Piel, Géraldine  (4)
Degey, Manon  (3)
Nicolas, Emilien (2)
Main Referenced Keywords
Breast cancer (1); dilemma (1); immunogenicity (1); Ionizable lipids (1); lipid nanoparticle (1);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (4)

Publications (total 4)

The most downloaded
102 downloads
Berger, M., Degey, M., Curnel, A., Evrard, B., & Piel, G. (2025). The benefits of emerging alternatives to PEG for lipid nanoparticle RNA delivery systems. Nanomedicine, 1 - 3. doi:10.1080/17435889.2025.2500917 https://hdl.handle.net/2268/331579

The most cited

3 citations (OpenAlex)

Berger, M., Degey, M., Curnel, A., Evrard, B., & Piel, G. (2025). The benefits of emerging alternatives to PEG for lipid nanoparticle RNA delivery systems. Nanomedicine, 1 - 3. doi:10.1080/17435889.2025.2500917 https://hdl.handle.net/2268/331579

Curnel, A., Nicolas, E., Nijskens, C., Torres, D., Evrard, B., Piel, G., & Berger, M. (30 January 2026). Impact of lipid composition on gene delivery efficiency of siRNA lipid nanoparticle in breast cancer [Paper presentation]. CIRM Day.

Curnel, A., Degey, M., Torres, D., Evrard, B., Nicolas, E., Piel, G., & Berger, M. (01 October 2025). Optimization of siRNA-based lipid nanoparticle formation to enhance gene delivery and improve efficacy in breast cancer treatment [Poster presentation]. 5th Conference on Innovation in Drug Delivery.

Berger, M., Degey, M., Curnel, A., Evrard, B., & Piel, G. (2025). The benefits of emerging alternatives to PEG for lipid nanoparticle RNA delivery systems. Nanomedicine, 1 - 3. doi:10.1080/17435889.2025.2500917
Peer Reviewed verified by ORBi

Curnel, A., Degey, M., Evrard, B., Piel, G., & Berger, M. (31 March 2025). Production and characterization of lipid nanoparticle formulations with different ionizable lipids in order to compare their cell efficacy and toxicity [Paper presentation]. 22nd Forum of Pharmaceutical Sciences, La Roche-en-Ardenne, Belgium.
Editorial reviewed

Contact ORBi